Is MindBio Therapeutics Corp halal to invest in?

As of July 2026, MindBio Therapeutics Corp WF6.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is MindBio Therapeutics Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MindBio Therapeutics Corp using these criteria to determine its compliance status.

Can Muslims buy shares of MindBio Therapeutics Corp?

Muslim investors may consider investing in MindBio Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is MindBio Therapeutics Corp classified as NOT HALAL?

Musaffa determines the Shariah status of MindBio Therapeutics Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for MindBio Therapeutics Corp updated?

The Shariah compliance status of MindBio Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like MindBio Therapeutics Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of MindBio Therapeutics Corp?

You can check the latest Shariah compliance status of MindBio Therapeutics Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

MindBio Therapeutics Corp WF6.BE

Last Updated: Feb 10, 12:00 AM·BE

WF6.BE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, MindBio Therapeutics Corp is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

MindBio Therapeutics Corp. Stock Analysis WF6.BE

Germany N/A Small Cap Report: Q1, 2026

Mindbio Therapeutics Corp. engages in the provision of developing psychedelic medicines to treat medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-05-05. The company creates novel and emerging treatments for mental health conditions and is conducting take-home Microdosing (MB22001) human clinical trials. MB22001 is its lead candidate drug, a titratable form of Lysergic Acid Diethylamide designed for take-home microdosing. The company is focused on microdosing of psychedelic medicines and is advancing its drug and technology through clinical trials. The company develops a multidisciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase I clinical trials in 80 healthy participants and has completed Phase II clinical trials in patients with Major Depressive Disorder. Underway are Phase IIB trials, one in cancer patients experiencing existential distress and another in patients with Major Depressive Disorder. The company invests in research that forms the basis for developing novel and clinically proven treatments.

Key Statistics of MindBio Therapeutics Corp (WF6.BE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.01€0.02

Today's Open

€0.02

Volume

21.30K

P/E Ratio (TTM)

Financial Metrics & Statements of MindBio Therapeutics Corp (WF6.BE)

Super Investors Invested in MindBio Therapeutics Corp (WF6.BE)

FAQ's for MindBio Therapeutics Corp (WF6.BE)

As of July 2026, MindBio Therapeutics Corp WF6.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes MindBio Therapeutics Corp using these criteria to determine its compliance status.
Muslim investors may consider investing in MindBio Therapeutics Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of MindBio Therapeutics Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of MindBio Therapeutics Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of MindBio Therapeutics Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.